Glucosamine hydrochloride exerts a protective effect against unilateral ureteral obstruction-induced renal fibrosis by attenuating TGF-β signaling
Open Access
- 27 September 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Molecular Medicine
- Vol. 91 (11), 1273-1284
- https://doi.org/10.1007/s00109-013-1086-1
Abstract
Renal fibrosis is a common consequence of unilateral ureteral obstruction, which provides a useful model to investigate the pathogenesis of obstructive nephropathy and progressive renal fibrosis. Transforming growth factor (TGF-β1) has been recognized as a key mediator in renal fibrosis by stimulating matrix-producing fibrogenic cells and promoting extracellular matrix deposition. Therefore, considerable efforts have been made to regulate TGF-β signaling for antifibrotic therapy. Here, we investigated the mode of action of glucosamine hydrochloride (GS-HCl) on TGF-β1-induced renal fibrosis. In the obstructed kidneys and TGF-β1-treated renal cells, GS-HCl significantly decreased renal expression of α-smooth muscle actin, collagen I, and fibronectin. By investigating the inhibitory mechanism of GS-HCl on renal fibrosis, we found that GS-HCl suppressed TGF-β signaling by inhibiting N-linked glycosylation of the type II TGF-β receptor (TβRII), leading to an inefficient trafficking of TβRII to the membrane surface. Defective N-glycosylation of TβRII further suppressed the TGF-β1-binding to TβRII, thereby decreasing TGF-β signaling. Notably, GS-HCl treatment significantly reduced TGF-β1-induced up-regulation of Smad2/3 phosphorylation and transcriptional activity in vivo and in vitro. Taken together, GS-HCl-mediated regulation of TGF-β signaling exerted an antifibrotic effect, thereby ameliorating renal fibrosis. Our study suggests that GS-HCl would be a promising agent for therapeutic intervention for preventing TGF-β1-induced renal fibrosis in kidney diseases. Glucosamine-mediated attenuation of TGF-β signaling ameliorates renal fibrosis in vivo TGF-β1-induced fibrogenic action is reduced by glucosamine in vitro N-glycosylation of the type II TGF-β receptor is suppressed by glucosamine Glucosamine-induced defective N-glycosylation of TβRII decreases TGF-β signaling.Keywords
This publication has 37 references indexed in Scilit:
- TGF-β sensitivity is determined by N-linked glycosylation of the type II TGF-β receptorBiochemical Journal, 2012
- Glucosamine Modulates TNF-α–Induced ICAM-1 Expression and Function Through O-Linked and N-Linked Glycosylation in Human Retinal Pigment Epithelial CellsInvestigative Ophthalmology & Visual Science, 2012
- EGFR Signaling Promotes TGFβ-Dependent Renal FibrosisJournal of the American Society of Nephrology, 2012
- Renal fibrosis: novel insights into mechanisms and therapeutic targetsNature Reviews Nephrology, 2010
- Vitamin D Receptor Attenuates Renal Fibrosis by Suppressing the Renin-Angiotensin SystemJournal of the American Society of Nephrology, 2010
- 10mM glucosamine prevents activation of proADAMTS5 (aggrecanase-2) in transfected cells by interference with post-translational modification of furinOsteoarthritis and Cartilage, 2010
- The Role of N-Glycosylation in Function and Surface Trafficking of the Human Dopamine TransporterPublished by Elsevier BV ,2004
- Mechanisms of TGF-β Signaling from Cell Membrane to the NucleusCell, 2003
- N‐linked glycosylation sites determine HERG channel surface membrane expressionThe Journal of Physiology, 1999
- The Banff 97 working classification of renal allograft pathologyKidney International, 1999